Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
Clinical trial NCT05707910 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05707910
- Sponsor
- West China Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-08
- Primary completion
- 2024-04-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.